Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Scott D. Solomon et al.|New England Journal of Medicine|2019Cited by 6.8k
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D. Anker, Milton Packer, Javed Butler et al.|New England Journal of Medicine|2021Cited by 4.6k
New Markers of Inflammation and Endothelial Cell ActivationPaul E. Szmitko, Subodh Verma|Circulation|2003Cited by 733
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D. Solomon, Subodh Verma, Eva Gonçalvesová et al.|New England Journal of Medicine|2024Cited by 693
Endothelial cell control of thrombosisJonathan W. Yau, Subodh Verma|BMC Cardiovascular Disorders|2015Cited by 678